Cargando…
Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents
We used a nationwide population registry in South Korea to estimate the effect of a second booster dose of mRNA COVID-19 vaccine on the risk for laboratory-confirmed SARS-CoV-2 infection, critical infection, and death in immunocompromised persons and long-term care facility (LTCF) residents. During...
Autores principales: | Kim, Yoo-Yeon, Choe, Young June, Kim, Jia, Kim, Ryu Kyung, Jang, Eun Jung, Park, Seon Kyeong, Lim, Do-Sang, Yi, Seonju, Lee, Sangwon, Kwon, Geun-Yong, Shin, Jee Yeon, Choi, Sang-Yoon, Jeong, Mi Jin, Park, Young-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622254/ https://www.ncbi.nlm.nih.gov/pubmed/36191615 http://dx.doi.org/10.3201/eid2811.220918 |
Ejemplares similares
-
Effectiveness of A Fourth Dose of COVID-19 mRNA Vaccine in the Elderly Population During the Omicron BA.2 and BA.5 Circulation: A Nationwide Cohort Study in Korea (K-COVE)
por: Park, Seon Kyeong, et al.
Publicado: (2023) -
Effectiveness of Heterologous COVID-19 Vaccine Booster in Korean Elderly Population, 2022
por: Park, Seon Kyeong, et al.
Publicado: (2023) -
Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
por: Kim, Yoo-Yeon, et al.
Publicado: (2023) -
Presumed population immunity to SARS-CoV-2 in South Korea, April 2022
por: Jang, Eun Jung, et al.
Publicado: (2022) -
SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021
por: Yi, Seonju, et al.
Publicado: (2022)